Learn More
Medchemexpress LLC AES-135 100mg | 2361659-61-0 | 100 MG

Supplier: Medchemexpress LLC HY114483100MG
AES-135 is a hydroxamic acid-based pan-histone deacetylase (HDAC) inhibitor for research use. It inhibits HDAC3, HDAC6, HDAC8, and HDAC11 with reported IC50s of approximately 190-1,100 nM and has shown activity in an orthotopic pancreatic cancer mouse model.
- Pan-HDAC inhibitor with reported IC50s of ~190-1,100 nM.
- High reported purity: 98.2%.
- Available as solid or as 10 mM solution in DMSO formats.
- Offered in common research pack sizes, including 100 mg.
- Intended for in vitro and in vivo preclinical research use only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.